Penn Center for Research on Coronavirus and Other Emerging Pathogens

In response to the global SARS-CoV-2 crisis, and in close consultation with leadership of the Perelman School of Medicine, we are excited to announce the founding of the Penn Center for Research on Coronaviruses and Other Emerging Pathogens.

The goals of the Center are to 1) Accelerate SARS-CoV-2 research under Biosafety Level 3 containment, 2) Provide centralized information on SARS-CoV-2 research at Penn, and 3) Compile information on funding opportunities for research on SARS-CoV-2 and other emerging pathogens.

The Center will be led by Susan Weiss and Frederic Bushman. A highly distinguished set of researchers from Penn, CHOP and Wistar have agreed to serve as our internal advisory board.

Already Penn researchers are expanding stocks of SARS-CoV-2 and beginning studies of viral replication and inhibition. The Center is working to expand these efforts and to create new research opportunities in this area.

It is gratifying to see how rapidly the Penn community has come together to address this global health crisis. We have much to do.

Internal Advisory Board

Funding Sources

Papers on Coronaviruses from the Penn Community

Join our listserv and tell us about your research project!

DONATE NOW

ANNOUNCEMENTS

A single and two-stage, closed-tube, molecular test for the 2019 novel coronavirus at home, clinic, and points of entry, El-Tholoth, Bau and Song, in “ChemRxiv”

No credible evidence supporting claims of the laboratory engineering of SARS-CoV-2, Liu, Saif, Weiss and Su, “Emerging Microbes and Infections”

TWITTER

Excited to see that Christie's will be auctioning an NFT commemorating the breakthrough on modified mRNA vaccines from Kariko and Weissman at Penn. Please bid!!
https://www.christies.com/en/auction/the-university-of-pennsylvania-mrna-nft-vaccines-for-a-new-era-21692-nyr/

Susan Weiss will deliver the Nathanson Lecture Wednesday May 4 at noon ET. Her title is "40 Years of Coronaviruses". Hear a world expert on Coronaviruses provide a unique and sophisticated overview of work in the field!
https://primetime.bluejeans.com/a2m/live-event/xqbzwhrb

Ongoing analysis of SARS-CoV-2 sequences from virus in the Delaware Valley shows that we are now at ~80% omicron BA.2. Follow the progression of variants at our dashboard site:
https://microb120.med.upenn.edu/data/SARS-CoV-2/

The Bushman Lab hanging at the new Museum of Illusions in Philly. Thanks to Shantan, Hriju, and Carole for arranging such a fun outing!

The @PhillyInquirer featured our research and surveillance of COVID in the region to help answer the question, "will the surge in Europe hit us?"
https://www.inquirer.com/health/coronavirus/ba2-new-covid-variant-2022-omicron-surge-20220323.html?ff


Member Login